You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

CLINICAL TRIALS PROFILE FOR SARECYCLINE HYDROCHLORIDE

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for SARECYCLINE HYDROCHLORIDE

Subscribe to access the full database, or Subscribe
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT02320149 ↗	Study to Evaluate Safety & Efficacy of Sarecycline in Treatment of Acne	Completed	Allergan	Phase 3	2014-12-18	To evaluate the efficacy and safety of an approximate 1.5mg/kg/day dose of oral sarecycline compared to placebo in the treatment of moderate to severe facial acne vulgaris
NCT02320149 ↗	Study to Evaluate Safety & Efficacy of Sarecycline in Treatment of Acne	Completed	Almirall, S.A.	Phase 3	2014-12-18	To evaluate the efficacy and safety of an approximate 1.5mg/kg/day dose of oral sarecycline compared to placebo in the treatment of moderate to severe facial acne vulgaris
NCT02320149 ↗	Study to Evaluate Safety & Efficacy of Sarecycline in Treatment of Acne	Completed	Warner Chilcott	Phase 3	2014-12-18	To evaluate the efficacy and safety of an approximate 1.5mg/kg/day dose of oral sarecycline compared to placebo in the treatment of moderate to severe facial acne vulgaris
NCT02322866 ↗	Randomized, Double-blind, Placebo-controlled Study to Evaluate Safety & Efficacy of Sarecycline in Treatment of Acne	Completed	Allergan	Phase 3	2014-12-03	To evaluate the efficacy and safety of an approximate 1.5 mg/kg/day dose of oral sarecycline compared to placebo in the treatment of moderate to severe facial acne vulgaris
NCT02322866 ↗	Randomized, Double-blind, Placebo-controlled Study to Evaluate Safety & Efficacy of Sarecycline in Treatment of Acne	Completed	Almirall, S.A.	Phase 3	2014-12-03	To evaluate the efficacy and safety of an approximate 1.5 mg/kg/day dose of oral sarecycline compared to placebo in the treatment of moderate to severe facial acne vulgaris
NCT02322866 ↗	Randomized, Double-blind, Placebo-controlled Study to Evaluate Safety & Efficacy of Sarecycline in Treatment of Acne	Completed	Warner Chilcott	Phase 3	2014-12-03	To evaluate the efficacy and safety of an approximate 1.5 mg/kg/day dose of oral sarecycline compared to placebo in the treatment of moderate to severe facial acne vulgaris
NCT02413346 ↗	A Multi-Center Open-Label Evaluation of the Safety of Sarecycline Tablets in the Treatment of Acne Vulgaris	Completed	Allergan	Phase 3	2015-03-20	Open-label study will evaluate the safety of an approximate 1.5 mg/kg/day dose of oral sarecycline in the long-term treatment of participants with moderate to severe facial acne vulgaris.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for SARECYCLINE HYDROCHLORIDE

Condition Name

Chart
Table

Condition Name for SARECYCLINE HYDROCHLORIDE
Intervention	Trials
Acne Vulgaris	4
Acne Rosacea	1
Ischemic Stroke, Acute	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for SARECYCLINE HYDROCHLORIDE
Intervention	Trials
Acne Vulgaris	4
Cerebral Infarction	1
Rosacea	1
Stroke	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for SARECYCLINE HYDROCHLORIDE

Trials by Country

Map
Table

Trials by Country for SARECYCLINE HYDROCHLORIDE
Location	Trials
United States	101
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for SARECYCLINE HYDROCHLORIDE
Location	Trials
Kentucky	5
New York	4
Nebraska	4
Michigan	4
Illinois	4
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for SARECYCLINE HYDROCHLORIDE

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for SARECYCLINE HYDROCHLORIDE
Clinical Trial Phase	Trials
Phase 4	1
Phase 3	4
Phase 2	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for SARECYCLINE HYDROCHLORIDE
Clinical Trial Phase	Trials
Completed	5
Not yet recruiting	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for SARECYCLINE HYDROCHLORIDE

Sponsor Name

Chart
Table

Sponsor Name for SARECYCLINE HYDROCHLORIDE
Sponsor	Trials
Allergan	4
Almirall, S.A.	4
Warner Chilcott	3
[disabled in preview]	4
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for SARECYCLINE HYDROCHLORIDE
Sponsor	Trials
Industry	11
Other	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.